Home › Neurofibrosarcoma › Massachusetts › Boston
Neurofibrosarcoma clinical trials in Boston, MA
4 studies for Neurofibrosarcoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RecruitingPhase 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
SPEARHEAD-3 Pediatric Study
RecruitingPhase 1/2
- Dana Farber Cancer Institute, Boston
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RecruitingPhase 1/2
- Dana Farber Cancer Institute, Boston
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
RecruitingPhase 2
- Dana Farber Cancer Institute (Data Collection Only), Boston
Neurofibrosarcoma trials in other cities
- Washington, DC6 studies
- New York City, NY6 studies
- St. Louis, MO4 studies
- Chicago, IL3 studies
- Mountain View, CA3 studies
- Edison, NJ3 studies
- Queens, NY3 studies
- Cincinnati, OH3 studies
- Houston, TX3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.